Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP-4 inhibitor and/or metformin in type 2 diabetes
ChiCTR-TRC-11001331Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Adipokine, Inflammation and 1 more. Started Jun 2011; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001331.